The activity of atorvastatin and rosiglitazone on CD38, ZAP70 and apoptosis in lymphocytes of B-cell chronic lymphocytic leukemia in vitro

被引:8
作者
Yavasoglu, Irfan [1 ]
Sargin, Gokhan [2 ]
Kadikoylu, Gurhan [1 ]
Karul, Aslihan [3 ]
Bolaman, Zahit [1 ]
机构
[1] Adnan Menderes Univ, Fac Med, Div Hematol, Aydin, Turkey
[2] Adnan Menderes Univ, Fac Med, Dept Internal Med, Aydin, Turkey
[3] Adnan Menderes Univ, Fac Med, Dept Biochem, Aydin, Turkey
关键词
Chronic lymphocytic leukemia; Apoptosis; In vitro; ACTIVATED RECEPTOR-GAMMA; COENZYME-A REDUCTASE; INDUCE APOPTOSIS; DOWN-REGULATION; PPAR-GAMMA; T-CELLS; EXPRESSION; LIGANDS; STATINS; PROTEIN;
D O I
10.1007/s12032-013-0603-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There are a number of studies about the effects of statins and thiazolidinediones on lymphocytes. However, there is no study about possible effects of atorvastatin and rosiglitazone on lymphocytes in patients with chronic lymphocytic leukemia (CLL). We aimed to investigate the effects of atorvastatin and rosiglitazone on CD38, ZAP-70, Annexin V and bcl-2 in lymphocytes of CLL in vitro. Seven (4 males and 3 females) patients with CLL with average age of 56 +/- 8 years were enrolled to the study. The mean values of laboratory tests were as follows: hemoglobin: 12 +/- 1.8 g/dl; hematocrit: % 35 +/- 6; platelet count: 156,000 +/- 68,000/mm(3); leukocyte count: 50,500 +/- 38,700/mm(3); and lymphocyte count: 45,700 +/- 38,100/mm(3). The study was performed in three cell cultures groups. Mononuclear cells of blood samples from peripheral veins were separated by Ficoll method. On culture plate with 24 wells, it was suspended with 2 ml RPMI 1640. Then, the plates were incubated in % 5 CO2 at 37 degrees C for 24 h. 5 mu M atorvastatin-calcium was given to first group, 2 mu M rosiglitazone maleate was given to second group, and the third group was included in the study as control group. After 24 h, the expressions of CD5, CD38, ZAP-70 and Annexin V by using flow cytometry with EPICS XL-MCL and the levels of bcl-2 by using ELISA method were re-evaluated. Two-paired Student's t test was used for comparison of the results, and p < 0.05 was accepted as a significance level. While atorvastatin and rosiglitazone did not affect the expression of CD38 and the level of bcl-2, these drugs significantly increased the level of Annexin V when compared with control group (p < 0.001). Both drugs significantly decreased the expressions of CD5 (p = 0.03) and ZAP-70 (p < 0.05) compared with control group. Atorvastatin and rosiglitazone increased apoptosis in lymphocytes of CLL in vitro. Moreover, these drugs decreased the expressions of CD5 and ZAP-70. These drugs must be studied in more detail in the pathogenesis and treatment for CLL.
引用
收藏
页数:7
相关论文
共 49 条
[1]   In vitro anti-oxidant and dna protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor rosuvastatin [J].
Ajith, T. A. ;
Riji, T. ;
Anu, V. .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (5-6) :625-629
[2]   A comparative study on the antimutagenicity of atorvastatin and lovastatin against directly acting mutagens [J].
Ajith, T. A. ;
Soja, M. .
CELL BIOLOGY AND TOXICOLOGY, 2006, 22 (04) :269-274
[3]   Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's Lymphoma Ascites tumor in mice [J].
Ajith, TA ;
Harikumar, KB ;
Thasna, H ;
Sabu, MC ;
Babitha, NV .
CLINICA CHIMICA ACTA, 2006, 366 (1-2) :322-328
[4]  
Ajith Thekkoottuparambil Ananthanarayanan, 2008, J Exp Ther Oncol, V7, P291
[5]   Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells [J].
Bairey, O. ;
Vanichkin, A. ;
Shpilberg, O. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2010, 32 (01) :E77-E85
[6]  
BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO
[7]  
2-V
[8]   3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes [J].
Blanco-Colio, LM ;
Muñoz-García, B ;
Martín-Ventura, JL ;
Lorz, C ;
Díaz, C ;
Hernández, G ;
Egido, J .
CIRCULATION, 2003, 108 (12) :1506-1513
[9]   Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme a reductase without decreasing cholesterol synthesis [J].
Blank, Norbert ;
Schiller, Martin ;
Krienke, Stefan ;
Busse, Freja ;
Schaetz, Birgit ;
Ho, Anthony D. ;
Kalden, Joachim R. ;
Lorenz, Hanns-Martin .
JOURNAL OF IMMUNOLOGY, 2007, 179 (06) :3613-3621
[10]   Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia [J].
Boelens, Jerina ;
Lust, Sofie ;
Van Bockstaele, Femke ;
Van Gele, Mireille ;
Janssens, Ann ;
Derycke, Lara ;
Vanhoecke, Barbara ;
Philippe, Jan ;
Bracke, Marc ;
Offner, Fritz .
LEUKEMIA RESEARCH, 2009, 33 (10) :1335-1343